Zayna Khayat, PhD., MaRS, Canada
|
|
- Bernice Howard
- 5 years ago
- Views:
Transcription
1 Zayna Khayat, PhD., MaRS, Canada MaRSMission: improve public health & Improve health system performance, & drive the new health economy Senior Advisor, Director of EXCITE program pre-market health technology evaluation Adjunct professor, Health strategy, RotmanSchool of Management, U. of Toronto Health and Life Science consulting - Boston Consulting Group & KPMG
2 Developing talent Growing ventures Opening markets Ensuringwide scale adoption of precision medicine technologies Zayna SEPTEMBER 19, 2015 Visit us at marsdd.com
3 Health Energy & Environment Finance & Commerce Work & Learning 9/26/2016
4 The Future of Health 1. Timing Today: System Reactive, delayed, sick care Future: Citizen Anticipatory, predictive 2. Tailoring 3. Modality 1 size fits all [none] Institution-centred Individualized,configurable,precise Dephysicalized, Digi-cal 4. Duration 5. Power 6. Biz Model Episodic, intermittent, silo d Provider Volume-based Continuous, team People-powered Outcomes-based Zayna Khayat MaRS Discovery District (2016) 4
5 Reactive, sick care 1 size fits all [none] Institution-centred Episodic, intermittent, silo d Provider Volume-based Visit us at marsdd.com Innovation capacity Outdated regul n Today: System Push vs. pull Infrastructure Procurement/diffusion Consumer User Payer Outdated delivery models Information asymmetry Fragmentation / lack of scale Incentives/payment schemes Future: Citizen Anticipatory, proactive, predictive Individualized,precise Dephysicalized, Digi-cal Continuous team People-powered Outcomes-based Zayna Khayat MaRS Discovery District (2016) 5 Developing talent Growing ventures Opening markets
6 Invention + Adoption = Innovation Invention Adoption
7 Today: System Reactive, sick care 1 size fits all [none] Institution-centred Episodic, intermittent, silo d Provider Volume-based Visit us at marsdd.com Innovation capacity Innovation capacity Outdated regul n Procurement Push instead of pull Infrastructure Procurement Push instead of / diffusion pull Consumer User Payer Outdated delivery models Information asymmetry Fragmentation / lack of scale Incentives/payment schemes Future: Citizen Anticipatory, proactive, predictive Individualized,precise Dephysicalized, Digi-cal Continuous team People-powered Outcomes-based Zayna Khayat MaRS Discovery District (2016) 7 Developing talent Growing ventures Opening markets
8 Today: System Reactive, sick care 1 size fits all [none] Institution-centred Episodic, intermittent, silo d Provider Volume-based Innovation capacity 1. Innovation capacity Outdated regul n Procurement Infrastructure Push instead of pull Consumer User Payer Outdated delivery models Information asymmetry Fragmentation / lack of scale Incentives/payment schemes Future: Citizen Anticipatory, proactive, predictive Individualized,precise Dephysicalized, Digi-cal Continuous team People-powered Outcomes-based Zayna Khayat MaRS Discovery District (2016) 8
9 9/26/2016
10 The problem:incumbent institutions largely designed to stifle innovation Zayna Khayat MaRS Discovery District (2016) 10
11 Corporate vs. Startup A permanent organization designed to execute a repeatable and scalable business model A temporary organization designed to search for a repeatable and scalable business model Source: Steve Blank Zayna Khayat MaRS Discovery District (2016) 11
12 MaRS Corporate Innovation Platform Roland Harwood, Open Innovation (2014) (Reproduced) Zayna Khayat MaRS Discovery District (2016) 12
13 Corporate Innovation Partners
14 Health Innovation Centre Meetup (Hosted by MaRS)
15 40,000 square MaRS health startups incubated Rx + med tech + digital health + consumer Access to J&J global networks No strings attached model
16 Outdated regul n Today: System Reactive, sick care 1 size fits all [none] Institution-centred Episodic, intermittent, silo d Provider Volume-based Innovation capacity Procurement 2. Push instead of pull Infrastructure Push instead of pull Consumer User Payer Outdated delivery models Information asymmetry Fragmentation / lack of scale Incentives/payment schemes Future: Citizen Anticipatory, proactive, predictive Individualized,precise Dephysicalized, Digi-cal Continuous team People-powered Outcomes-based Zayna Khayat MaRS Discovery District (2016) 16
17 Hurdles to full value capture from med tech Patients accessing technology (+ Obsolescence of old) Developing talent Growing ventures Opening markets 1. Evidence 6. Adoption 2. Licensing 3. HTA, Coverage decision 4. Funding, fee codes 5. Procurement Time Visit us at marsdd.com
18 Pull model for innovation U Pre-Market Post-Market Diffusion E f f e c t i v Effectiveness e n e s s Systematic review Systematic review Cost Effectiveness Cost Effectiveness (CE) Obsolescence Efficacy Safety Value (CE) Affordability Ethical & societal Post-market conditions Efficacy Safety Value (CE) Affordability Ethical & societal Post-market conditions Yes Unconditional No TIME Regulation Reimbursement Zayna Khayat MaRS Discovery District (2016) 18
19 EXCELLENCE IN CLINICAL INNOVATION & TECHNOLOGY EVALUATION Health System Regulators + 24 research hospitals + >30 community health orgs Academic HTA + 15 others Industry Zayna Khayat MaRS Discovery District (2016) 19
20 P R E L I M I N A R Y EXCITE International: Extending the model globally International Board International Scientific Collaboration Develop accepted frameworks to assist EXCITE International affiliates in their work EXCITE INTERNATIONAL SECRETARIAT International Leadership Centres Coordinates multinational evaluations for MNEs and SMEs Facilitates MC quality frameworks Advises/assists members in setting up local EXCITE like operations EXCITE International Affiliates CANADA(MARS) US UK NL NZ Others
21 Outdated regul n Today: System Reactive, sick care 1 size fits all [none] Institution-centred Episodic, intermittent, silo d Provider Volume-based Visit us at marsdd.com Innovation capacity Procurement Infrastructure 3. Push Procurement instead of / pull diffusion Consumer User Payer Outdated delivery models Information asymmetry Fragmentation / lack of scale Incentives/payment schemes Future: Citizen Anticipatory, proactive, predictive Individualized,precise Dephysicalized, Digi-cal Continuous team People-powered Outcomes-based Zayna Khayat MaRS Discovery District (2016) 21 Developing talent Growing ventures Opening markets
22 Exponential tech. Linear health system Time to reach 50 M users 17 yrs Average time from evidence to practice in medicine: 17 years Vala Afshar; Citi Digital Strategy Team; Michael Felton, The New York Times (in HBR.org) 22
23 REACH: Outcomes-based procurement Resources for Evaluating, Adopting and Capitalizing on Innovative Healthcare Technology A program to help Ontario healthcare providers use new ways to evaluate, buy and more rapidly adopt beneficial medical technologies addressing highpriority health system problems. REACH will provide a pathway for innovative technologies to earn access to the Ontario market. Zayna Khayat MaRS Discovery District (2016) 23
24 Procurement by Co-Design Program $50K to help health organizations buy innovative med tech INITIATION DESIGN & PROTOTYPE 10 weeks 32 weeks Provider Challenge Briefs Design Discovery Vendor Innovator Briefs Vendor Selection Prototype $25K PROCURE Procurement voucher $25K Evaluate Final evaluation Zayna Khayat MaRS Discovery District (2016) 24
25 Outdated regul n Today: System Reactive, sick care 1 size fits all [none] Institution-centred Episodic, intermittent, silo d Provider Volume-based Innovation capacity Procurement Infrastructure Push instead of pull Consumer User Payer Outdated delivery models 4. Information asymmetry Fragmentation / lack of scale Incentives/payment schemes Future: Citizen Anticipatory, proactive, predictive Individualized,precise Dephysicalized, Digi-cal Continuous team People-powered Outcomes-based Zayna Khayat MaRS Discovery District (2016) 25
26 Information Asymmetry Source: Lucien Engelen, Radboud Medical University Centre (Netherlands) Zayna Khayat MaRS Discovery District (2016) 26
27 Data Everywhere Developing talent Growing ventures Opening markets Medical record = Phenome Visit us at marsdd.com Source: Exponential Medicine 2015 Zayna Khayat MaRS Discovery District (2016) 27
28 MyHealth: Data flows to/thru Patient Zayna Khayat MaRS Discovery District (2016) Source: Lucien Engelen, Radboud Medical University Centre (Netherlands) 28
29 Outdated regul n Today: System Reactive, sick care 1 size fits all [none] Institution-centred Episodic, intermittent, silo d Provider Volume-based Innovation capacity Procurement Infrastructure Push instead of pull Consumer User Payer Outdated delivery models Information asymmetry Fragmentation / lack of scale 5. Incentives/payment schemes schemes Future: Citizen Anticipatory, proactive, predictive Individualized,precise Dephysicalized, Digi-cal Continuous team People-powered Outcomes-based Zayna Khayat MaRS Discovery District (2016) 29
30 HowGoogleWorks.Net Zayna Khayat MaRS Discovery District (2016) 30
31 Buying outcomes, not products Value = Outcomes Costs All or some portion of payment made to a product or service provider is contingent on meeting a set of results Zayna Khayat MaRS Discovery District (2016) 31
32 New outcomes financing vehicles Social impact bond in hypertension Intermediary Investor(s) Success payments Capital investment Service provider Success payments Outcomes payer Health intervention Target population Outcome measures Evaluator
33 Developing talent Growing ventures Opening markets Invention + Adoption = Innovation Visit us at marsdd.com
34 KEEP CALM & KEEP INNOVATING Developing talent Growing ventures Opening markets Zayna Khayat, Ph.D. MaRS INNOVATION B ECAUSE THE FUTURE MAT TERS Visit us at marsdd.com Zayna Khayat MaRS Discovery District (2016) 34
Centre for the Advancement of Health Innovations (CAHI)
Centre for the Advancement of Health Innovations (CAHI) Excellence in Clinical Innovation and Technology Evaluation Monday, April 16 th, 2012 The Old Mill Inn and Spa, Toronto ON Leslie Levin MB, MD, FRCP
More informationScottish Health and Life Sciences Innovation Workshop. The Industrial Strategy Challenge Fund
Scottish Health and Life Sciences Innovation Workshop The Industrial Strategy Challenge Fund Ian Campbell Innovate UK, Director of Health &Life Sciences Email:Ian.Campbell@innovateuk.gov.uk Twitter: @IanWCampbell
More informationDecember Eucomed HTA Position Paper UK support from ABHI
December 2008 Eucomed HTA Position Paper UK support from ABHI The Eucomed position paper on Health Technology Assessment presents the views of the Medical Devices Industry of the challenges of performing
More informationHealth Technology Assessment: What are the key challenges to assess medical devices? Rosanna Tarricone, PhD Director CERGAS Scientific Director EHTI
Health Technology Assessment: What are the key challenges to assess medical devices? Rosanna Tarricone, PhD Director CERGAS Scientific Director EHTI SAMED, Annual Conference, May 29 th 2014 From «Does
More informationMedTech Europe position on future EU cooperation on Health Technology Assessment (21 March 2017)
MedTech Europe position on future EU cooperation on Health Technology Assessment (21 March 2017) Table of Contents Executive Summary...3 The need for healthcare reform...4 The medical technology industry
More informationWritten Submission for the Pre-Budget Consultations in Advance of the 2019 Budget By: The Danish Life Sciences Forum
Written Submission for the Pre-Budget Consultations in Advance of the 2019 Budget By: The Danish Life Sciences Forum List of recommendations: Recommendation 1: That the government creates a Life Sciences
More informationReduce cost sharing and fees Include other services. Services: which services are covered? Population: who is covered?
3.3 Assessment: National health technology assessment unit 3.3.1 Introduction Health systems throughout the world are struggling with the challenge of how to manage health care delivery in resource-constrained
More informationConvergence and Differentiation within the Framework of European Scientific and Technical Cooperation on HTA
EUnetHTA European network for Health Technology Assessment Convergence and Differentiation within the Framework of European Scientific and Technical Cooperation on HTA University of Tokyo, October 24,
More informationHorizon Societal Challenge 1: Health, demographic change and wellbeing. Jeremy Bray DG Research & Innovation European Commission
Horizon 2020 Societal Challenge 1: Health, demographic change and wellbeing Jeremy Bray DG Research & Innovation European Commission National NHS day Leeds, UK, 29 January 2014 What is Horizon 2020? The
More informationAdvances and Perspectives in Health Information Standards
Advances and Perspectives in Health Information Standards HL7 Brazil June 14, 2018 W. Ed Hammond. Ph.D., FACMI, FAIMBE, FIMIA, FHL7, FIAHSI Director, Duke Center for Health Informatics Director, Applied
More informationHTA Position Paper. The International Network of Agencies for Health Technology Assessment (INAHTA) defines HTA as:
HTA Position Paper The Global Medical Technology Alliance (GMTA) represents medical technology associations whose members supply over 85 percent of the medical devices and diagnostics purchased annually
More informationHow can public and social innovation build a more inclusive economy?
How can public and social innovation build a more inclusive economy? Friday 27th January 2017 Nesta Guest seespark Welcome and Introduction Madeleine Gabriel Head of Inclusive Innovation, International
More informationPatient safety and optimal performance:
Patient safety and optimal performance: a holistic framework for medical devices Michael Cheng Independent Patient Safety Advocate cheng12@sympatico.ca Canadian Agency for Drugs and Technologies in Health
More informationHealth Innovation Manchester
Health Innovation Manchester Accelerating innovation Discover Develop Deploy Our vision is to be a recognised international leader in accelerating innovation that transforms citizens health and wellbeing
More informationCentre for Healthcare Technologies
Centre for Healthcare Technologies Steve Morgan www.healthcaretechnologies.ac.uk Launched 29.2.16 The future: doom and gloom? 2011 2015 Healthcare Public Patients Clinicians Policy RCUK Regulators NHS
More informationexecutives are often viewed to better understand the merits of scientific over commercial solutions.
Key Findings The number of new technology transfer licensing agreements earned for every $1 billion of research expenditure has fallen from 115 to 109 between 2004 and. However, the rate of return for
More informationSMART PLACES WHAT. WHY. HOW.
SMART PLACES WHAT. WHY. HOW. @adambeckurban @smartcitiesanz We envision a world where digital technology, data, and intelligent design have been harnessed to create smart, sustainable cities with highquality
More informationFDA Centers of Excellence in Regulatory and Information Sciences
FDA Centers of Excellence in Regulatory and Information Sciences February 26, 2010 Dale Nordenberg, MD novasano HEALTH AND SCIEN Discussion Topics Drivers for evolution in regulatory science Trends in
More informationEvidence Standards and AI
Evidence Standards and AI Dr Indra Joshi Digital Health and AI, Clinical Lead January 2019 We are creating a digital ecosystem that provides a consistent and trusted experience across digital tools and
More informationDigital Identity Innovation Canada s Opportunity to Lead the World. Digital ID and Authentication Council of Canada Pre-Budget Submission
Digital Identity Innovation Canada s Opportunity to Lead the World Digital ID and Authentication Council of Canada Pre-Budget Submission August 4, 2017 Canadian governments, banks, telcos, healthcare providers
More informationHealth Technology Assessment and the European Network for HTA
Health Technology Assessment and the European Network for HTA www.eunethta.eu Marcial Velasco Garrido, Technische Universität Berlin for the European Network for HTA, EUnetHTA Outline What is Health Technology
More informationExploratory Process on the Future of the Medical Devices
Ref. Ares(2015)1962347-08/05/2015 Exploratory Process on the Future of the Medical Devices Potential themes for further reflection at the European level and Issues identified by the Members Content A-
More informationEarly HTA to inform value driven market access and reimbursement planning
Early HTA to inform value driven market access and reimbursement planning Lotte MG Steuten, PhD Associate Prof. Health Technology & Services Research Program Director Health Sciences University of Twente,
More informationScience, technology and engineering for innovation and capacity-building in education and research UNCTAD Wednesday, 28 November 2007
Science, technology and engineering for innovation and capacity-building in education and research UNCTAD Wednesday, 28 November 2007 I am honored to have this opportunity to present to you the first issues
More informationMedical Device Industry in India
Medical Device Industry in India The Evolving Landscape, Opportunities and Challenges September 2017 skpgroup.com AdvaMed (the Advanced Medical Technology Association) is the world s leading medical technology
More informationInnovation in HTA: What is the additional value?
Innovation in HTA: What is the additional value? Stirling Bryan Centre for Clinical Epidemiology & Evaluation, Vancouver Coastal Health Research Institute School of Population & Public Health, UBC My co-authors
More informationIP and Technology Management for Universities
IP and Technology Management for Universities Yumiko Hamano Senior Program Officer WIPO University Initiative Innovation and Technology Transfer Section, Patent Division, WIPO Outline! University and IP!
More informationCDP-EIF ITAtech Equity Platform
CDP-EIF ITAtech Equity Platform New financial instruments to support technology transfer in Italy TTO Circle Meeting, Oxford June 22nd 2017 June, 2017 ITAtech: the "agent for change" in TT landscape A
More informationSmart cities: A human-centered approach Engineering and Construction Conference June 20 22, 2018
Smart cities: A human-centered approach 2018 Engineering and Construction Conference June 20 22, 2018 Agenda Topic Smart City Overview Content Drivers, Framework, Evolution Client Stories Success Factors
More informationDigitising European Industry: A key role for Digital Innovation Hubs in the regions
Digitising European Industry: A key role for Digital Innovation Hubs in the regions Anne-Marie Sassen, Deputy Head of Unit DG CONNECT/A2 - European Commission anne-marie.sassen@ec.europa.eu #DigitiseEU
More informationAndalusian Agency for Health Technology Assessment (AETSA)
Andalusian Agency for Health Technology Assessment (AETSA) Seville, 22 nd of July, 2016 Comments on the concept paper Facilitating the translation of advanced therapies to patients in Europe 1 Introduction
More informationChanging Healthcare Procurement Approaches in Canada and Beyond
Changing Healthcare Procurement Approaches in Canada and Beyond HSCN Conference 2015 May 13, 2015 Dr. Gabriela Prada Director, Health Innovation Policy The Conference Board of Canada prada@conferenceboard.ca
More informationFinancing the Technology Innovation of SMEs in Korea. Hong Jae-Keun (Ph.D)
Financing the Technology Innovation of SMEs in Korea Hong Jae-Keun (Ph.D) CONTENTS Ⅰ. Why SME Technology Financing Matters? Ⅱ. How Korean SMEs Finance for R&D? Ⅲ. Sophisticated Technology Financing Infrastructure
More informationSTI for reducing inequality within and among countries (SDG 10)
STI for reducing inequality within and among countries (SDG 10) Marta Pérez Cusó Technology and Innovation Section Trade, Investment and Innovation Division marta.perezcuso@un.org The inequality challenge
More informationOCHIS: Catalyst for Collaboration and Commercialization
OCHIS: Catalyst for Collaboration and Commercialization Waterloo Region Med Tech Bridging The Gap May 25, 2016 William Charnetski Chief Health Innovation Strategist Ministry of Health and Long Term Care
More informationEU s Innovative Medical Technology and EMA s Measures
EU s Innovative Medical Technology and EMA s Measures 27 October 2017 Summit symposium 25-27 October 2017, Kyoto, Japan Presented by Guido Rasi Executive Director, European Medicines Agency (EMA) An agency
More informationEHR Optimization: Why Is Meaningful Use So Difficult?
EHR Optimization: Why Is Meaningful Use So Difficult? Tuesday, March 1, 2016, 8:30-9:30 Elizabeth A. Regan, Ph.D. Department Chair Integrated Information Technology Professor Health Information Technology
More informationFostering SME innovation through cross-border cooperation
Fostering SME innovation through cross-border cooperation SMEs are key drivers of innovation serving as an important conduit for knowledge spill-overs. The 20 years have shown that entire sectors have
More informationMedicines Manufacturing in the UK 2017
Medicines Manufacturing in the UK 2017 Moderator: Magda Papadaki, PhD Head of Manufacturing Innovation The Association of the British Pharmaceutical Industry Medicines Manufacturing Industry Partnership
More informationInnovation & health connected. Business plan summary
Innovation & health connected Business plan summary 2017-18 CONTENTS Contents Introduction What do we do? Our five goals Goal 1: Transformation through innovation Goal 2: Economic growth Goal 3: Adoption
More informationHealth Technology Assessment of Medical Devices in Low and Middle Income countries: challenges and opportunities
Health Technology Assessment of Medical Devices in Low and Middle Income countries: challenges and opportunities Aleksandra Torbica, Carlo Federici, Rosanna Tarricone Centre for Research on Health and
More informationAdvancing Health and Prosperity. A Brief to the Advisory Panel on Healthcare Innovation
Advancing Health and Prosperity A Brief to the Advisory Panel on Healthcare Innovation November 2014 About ITAC ITAC is the voice of the Canadian information and communications technologies (ICT) industry
More informationHealth & Social Care Industrial Innovation
Health & Social Care Industrial Innovation Mr Andrew Fowlie Scottish Government Health Innovations Team SHINE North Sea Region Program 2014 2020 Scotland s Medical Technologies Landscape Imaging Non Imaging
More informationA Focus on Health Data Infrastructure, Capacity and Application of Outcomes Data
External Review of Pan-Canadian Health Organizations Thank you for the opportunity to provide input for your ongoing review of the Pan- Canadian Health Organizations (PCHOs). This submission is made on
More informationWORLD ANGEL INVESTMENT SUMMIT
2018 WORLD ANGEL INVESTMENT SUMMIT TORONTO, ON SEPTEMBER 25-27, 2018 ANGEL GROUP PARTNERSHIP OPPORTUNITIES The Flagship Event for the Global Angel Investor Community Event Details Date: September 25-27,
More informationEPSRC Funding for Engineering
EPSRC Funding for Engineering Philippa Hemmings Head of Process, Environment & Sustainability Setting the context of future strategy The world is changing It has never been more important to work together
More informationQ&A with Samira Salman
APRIL 2017 VOL. 5 ISSUE 122 R E P O R T Q&A with Samira Salman Founder of Salman Solutions. Principle Series: Family Office Insights sits down with Samira Salman to discuss successful deal structuring
More informationABHI Response to the Kennedy short study on Valuing Innovation
ABHI Response to the Kennedy short study on Valuing Innovation Introduction 1. The Association of British Healthcare Industries (ABHI) is the industry association for the UK medical technology sector.
More informationAn Introduction to China s Science and Technology Policy
An Introduction to China s Science and Technology Policy SHANG Yong, Ph.D. Vice Minister Ministry of Science and Technology, China and Senior Fellow Belfer Center for Science and International Affairs
More information(Fig.) JPMA Industry Vision 2025
2. JPMA Industry Vision 2025 Against the background of the changing environment surrounding the pharmaceutical industry and the future predictions *1, we prepared JPMA Industry Vision 2025 Bringing Innovation
More informationTechnology and Innovation in the NHS Scottish Health Innovations Ltd
Technology and Innovation in the NHS Scottish Health Innovations Ltd Introduction Scottish Health Innovations Ltd (SHIL) has, since 2002, worked in partnership with NHS Scotland to identify, protect, develop
More informationDiscovery: From Concept to the Patient - The Business of Medical Discovery. Todd Sherer, Ph.D.
Discovery: From Concept to the Patient - The Business of Medical Discovery Todd Sherer, Ph.D. Associate Vice President for Research and Director of OTT President Elect, Association of University Technology
More information@piret.tonurist o e. c d / o p s O P S I g o v o p s o e c d. o r g
@piret.tonurist oe.cd/opsi @OPSIgov opsi@oecd.org The Observatory of Public Sector Innovation exists since 2013 at the OECD. 2016 a team was assembled to build up different work-streams of the Observatory.
More informationResearch Development Request - Profile Template. European Commission
Research Development Request - Profile Template European Commission Research Development Request Profile The following table can be used as a template for drafting a Research Development Request profile.
More informationFuture City Glasgow. City of Glasgow
Future City Glasgow Scottish Government City Council Universities Commercial Collaboration City of Glasgow Population 600,000/1.2Million Largest City in Scotland (4th UK) One Unitary Local Authority 5
More information2. Evidence themes and their importance along the development path
1. The issue On 12 th July 2017, MedCity, Digital Health.London and BSI hosted a Digital Health Technology and Evidence Stakeholder workshop. It brought together the key experts for the innovation development
More informationONTARIO CENTRES OF EXCELLENCE OVERVIEW. Greater Peterborough Innovation Cluster Quarterly Membership Breakfast September 21, 2012
ONTARIO CENTRES OF EXCELLENCE OVERVIEW Greater Peterborough Innovation Cluster Quarterly Membership Breakfast September 21, 2012 ONTARIO CENTRES OF EXCELLENCE Established in 1987 by the Province of Ontario
More informationAGENDA. Whole Health Innovation Collaborative Meeting: Applying Precision to Preventative Health and Personalized Medicine
AGENDA Whole Health Innovation Collaborative Meeting: Applying Precision to Preventative Health and Personalized Medicine April 25, 2017 AGENDA 8:00 am Registration and Continental Breakfast (Guildhall
More informationOverview of Health Technology Assessment (HTA) from Asia Pacific Perspective
Overview of Health Technology Assessment (HTA) from Asia Pacific Perspective Hong Li, PhD., MPH Group Director, Bristol-Myers Squibb Adjunct Associate Professor University of Cincinnati, USA; and DUKE-NUS
More informationCross Linking Research and Education and Entrepreneurship
Cross Linking Research and Education and Entrepreneurship MATLAB ACADEMIC CONFERENCE 2016 Ken Dunstan Education Manager, Asia Pacific MathWorks @techcomputing 1 Innovation A pressing challenge Exceptional
More informationSponsored by WIPO, JPO, and IPOPHL Manila, 29 February 2016
National Workshop on Increasing the Capacity and Pace for Technology Scouting, Absorption, Adaptation through a Hub and Spoke Structure (IP Hub) Sponsored by WIPO, JPO, and IPOPHL Manila, 29 February 2016
More informationChristopher Kunney, CPHIT, MSMOT Executive Healthcare IT Strategist Phone: LinkedIn: Twitter:
Christopher Kunney, CPHIT, MSMOT Executive Healthcare IT Strategist Phone: 404.276.0738 Email: christopher@comcast.com LinkedIn: www.linkedin.com/in/christopherkunney Twitter: @HealthITProf Christopher
More informationTechnology and Innovation in the NHS Highlands and Islands Enterprise
Technology and Innovation in the NHS Highlands and Islands Enterprise Introduction Highlands and Islands Enterprise (HIE) welcomes the opportunity to respond to the Committee s call for views. We recognise
More informationOPEN INNOVATION AS A STRATEGIC MODEL OF MODERN BUSINESS
OPEN INNOVATION AS A STRATEGIC MODEL OF MODERN BUSINESS Nataliia Revutska, Assistant Prof. Taras Shevchenko National University of Kyiv, Ukraine Abstract The paper considers the characteristics of two
More informationA Science & Innovation Audit for the West Midlands
A Science & Innovation Audit for the West Midlands June 2017 Summary Report Key Findings and Moving Forward 1. Key findings and moving forward 1.1 As the single largest functional economic area in England
More information9 Vaccine SMEs' Needs
9 Vaccine SMEs' Needs As in most innovative sectors, SMEs play a critical role in bridging basic discoveries from academic research to clinical development 36. This could be seen over the last decade with
More informationTWO BY TWO: A METHODOLOGICAL PERSPECTIVE ON THE USE OF EVIDENCE TO SUPPORT THE VALUE OF A HEALTH TECHNOLOGY
TWO BY TWO: A METHODOLOGICAL PERSPECTIVE ON THE USE OF EVIDENCE TO SUPPORT THE VALUE OF A HEALTH TECHNOLOGY A/Prof Tracy Merlin Adelaide Health Technology Assessment (AHTA) School of Population Health
More informationAdopting Standards For a Changing Health Environment
Adopting Standards For a Changing Health Environment November 16, 2018 W. Ed Hammond. Ph.D., FACMI, FAIMBE, FIMIA, FHL7, FIAHSI Director, Duke Center for Health Informatics Director, Applied Informatics
More informationCollaborating with the Office of Technology Transfer
Collaborating with the Office of Technology Transfer Todd Sherer, Ph.D. Associate Vice President for Research and Executive Director Office of Technology Transfer Emory Owns Our IP As a condition of employment,
More informationKIC EIT Raw Materials
KIC EIT Raw Materials Text Text Dr. Lisa Maria T. O Donoghue Dublin 18.10.17 Picture source http://www.falconautoonline.com/incoming-material/ What is a EIT-KIC KIC (acronym of Knowledge Innovation Community)
More informationTechnology Leadership Course Descriptions
ENG BE 700 A1 Advanced Biomedical Design and Development (two semesters, eight credits) Significant advances in medical technology require a profound understanding of clinical needs, the engineering skills
More informationConverting Research into Innovation & Growth: SBIR, the University, and the Park
Converting Research into Innovation & Growth: SBIR, the University, and the Park Investing in Innovation: Promoting New Opportunities in the United Nations Economic Council for Europe Region Geneva, Switzerland
More informationBuilding global engagement in research Sources of funding for enabling international research collaborations
Building global engagement in research Sources of funding for enabling international research collaborations Jane Nicholson, Head of International Policy, EPSRC Engineering Professors Conference 16 April
More informationRIS3 from Strategic Orientations towards Policy Implementation: The Challenges Claire NAUWELAERS Independent expert in STI policy
S3 Platform Peer Review Workshop 15-16 May 2014, Portoroz RIS3 from Strategic Orientations towards Implementation: The Challenges Claire NAUWELAERS Independent expert in STI policy 1 KEY Challenges RIS3
More informationINNOVATION PERFORMANCE REVIEW OF ARMENIA Chapter 2: National Innovation System and Innovation Governance
INNOVATION PERFORMANCE REVIEW OF ARMENIA Chapter 2: National Innovation System and Innovation Governance Presentation by Rumen Dobrinsky European Alliance for Innovation Eighth session of the UNECE Committee
More informationDriving Innovation. Connect and Catalyse. Medicines and Healthcare the Global perspective (+10 years) Zahid Latif
Connect and Catalyse Medicines and Healthcare the Global perspective (+10 years) Zahid Latif % GDP spent on health OECD countries spent nearly $3.5trn in 2005 ($4.6 trillion in 2008) on healthcare services
More informationBiomedical Innovation Has Science Overtaken the System?
Adaptive Pathways for Transformative Medicinal Products. A New Paradigm with the Enhanced Application of Real-World Evidence? ISPOR 20 th Annual European Congress, Glasgow, Scotland Issue Panel 21, Wednesday,
More informationSUTTER HEALTH: A HEALTH DATA SHARING CASE STUDY
SUTTER HEALTH: A HEALTH DATA SHARING CASE STUDY Session 58, March 6, 2018 Steven Lane, MD, MPH Clinical Informatics Director, Privacy, Information Security & Interoperability, Sutter Health Dave Cassel
More informationWORLD ANGEL INVESTMENT SUMMIT
2018 WORLD ANGEL INVESTMENT SUMMIT TORONTO, ON SEPTEMBER 25-27, 2018 ANGEL GROUP PARTNERSHIP OPPORTUNITIES The Flagship Event for the Global Angel Investor Community Event Details Date: September 25-27,
More informationRole of Public funding in Enhancing Innovation
Role of Public funding in Enhancing Innovation Jari Romanainen 9.1.2013 Key barriers for innovation Institutional barriers Economic (e.g. high infrastructure costs) Social (e.g. traditions, established
More informationFinding Common Ground Webinar: Learning from the Ontario Tender Fruit Lab
Finding Common Ground Webinar: Learning from the Ontario Tender Fruit Lab June 28, 2016-12:00 to 1:00pm Claire Buré MaRS Solutions Lab Brent Mansfield BC Food Systems Network Sustainable Food Systems Working
More informationINNOVATION, HEALTH AND WEALTH ACCELERATING THE ADOPTION AND DIFFUSION IN THE NHS. MELANIE OGDEN DEPUTY DIRECTOR OF INNOVATION October 2013
INNOVATION, HEALTH AND WEALTH ACCELERATING THE ADOPTION AND DIFFUSION IN THE NHS MELANIE OGDEN DEPUTY DIRECTOR OF INNOVATION October 2013 The Challenge Our ambition must be for an NHS defined by its commitment
More informationHelping your business grow in the UK health system
Helping your business grow in the UK health system OVERVIEW PROVIDING INSIGHT AND HELPING YOU DELIVER INNOVATIVE PRODUCTS AND SERVICES TO THE NHS AND BEYOND. The health system is a complex and uncertain
More informationInternationalisation of STI
Internationalisation of STI Challenges for measurement Prof. Dr. Reinhilde Veugelers (KUL-EC EC-BEPA) Introduction A complex phenomenon, often discussed, but whose drivers and impact are not yet fully
More informationCorporate slide master
Corporate slide master Recommendations on Health & Wealth in Wales Ifan Evans Deputy Director Healthcare Innovation Welsh Government 1 What are these recommendations for? The Board s purpose is to: assist
More informationBusiness angels Published on Innovation Policy Platform (https://www.innovationpolicyplatform.org)
This section explores the role of business angels in financing prototype development and market demonstrations. It provides a full characterization of business angels (types, motivations, activities they
More informationWolfpack Investor Network. Investing in Our University s Best and Brightest
Wolfpack Investor Network Investing in Our University s Best and Brightest Overview Professionally Managed Angel Investing Experienced, professional full-time management team Backed by extensive resources
More informationUniversity IP and Technology Management. University IP and Technology Management
University IP and Technology Management Yumiko Hamano WIPO University Initiative Program Innovation Division WIPO WIPO Overview IP and Innovation University IP and Technology Management Institutional IP
More informationShared Investment. Shared Success. ReMAP Call for Proposals by Expression of Interest
Shared Investment. Shared Success. ReMAP 2.0 2018 Call for Proposals by Expression of Interest What s a BL-NCE? Refined Manufacturing Acceleration Process (ReMAP) is an innovation accelerator focused on
More informationCOURSE SCHEDULE
2018-2019 COURSE SCHEDULE Fall 1 Seven-Week: Aug. 27 Oct. 12, 2018 Business Formation & Structure -11:40am Legal & Regulatory Process ` Patent Business Formation & Structure -11:40am Research in, Business
More informationWHY FORM THE HEALTH CARE TEACHING COUNTY PARTNERSHIP?
WHY FORM THE HEALTH CARE TEACHING COUNTY PARTNERSHIP? Insanity: Doing the same thing over and over again and expecting different results. - Albert Einstein When you come to a fork in the road, take it.
More informationBritish Business Bank
British Business Bank Lewis Stringer, MEIF Senior Relationship Manager UKSPA Summer Conference, University of Lincoln 7 th June 2018 The British Business Bank The UK s national economic development bank
More informationEngineering Change Lab (Eng Lab) UNLOCKING THE POTENTIAL OF THE ENGINEERING PROFESSION IN CANADA SYSTEMICALLY, EXPERIMENTALLY & COLLABORATIVELY
Engineering Change Lab (Eng Lab) UNLOCKING THE POTENTIAL OF THE ENGINEERING PROFESSION IN CANADA SYSTEMICALLY, EXPERIMENTALLY & COLLABORATIVELY CO-CONVENED BY: FACILITATED BY: Introducing Eng Lab As the
More informationTranslational scientist competency profile
C-COMEND Competency profile for Translational Scientists C-COMEND is a two-year European training project supported by the Erasmus plus programme, which started on November 1st 2015. The overall objective
More informationMedtronic Payer Solutions
Medtronic Payer Solutions Delivering Cost-Savings Opportunities through Minimally Invasive Surgery In today s business environment, managing employee overhead and healthcare benefit costs necessitate that
More informationINNOVATION SCALE-UP POLICY: ACCESS AND OPPORTUNITY
INNOVATION SCALE-UP POLICY: ACCESS AND OPPORTUNITY Jennifer Clark Associate Professor, School of Public Policy Director, Center for Urban Innovation Georgia Institute of Technology, USA Georgia Tech s
More informationFinal Pitch Competition PROGRAM GUIDE. Wednesday, March 2, 2016 at HIMSS16 VENETIAN - PALAZZO - SANDS EXPO CENTER LEVEL 3 - LIDO 3104 LAS VEGAS, NV
Final Pitch Competition PROGRAM GUIDE Wednesday, March 2, 2016 at HIMSS16 VENETIAN - PALAZZO - SANDS EXPO CENTER LEVEL 3 - LIDO 3104 LAS VEGAS, NV #HITVenture #HIMSS16 1 Presented by: WEDNESDAY, MARCH
More informationREGIONAL INTELLIGENCE FOR REGIONAL STRATEGY. Dr. James Wilson Orkestra and Deusto Business School
REGIONAL INTELLIGENCE FOR REGIONAL STRATEGY Dr. James Wilson Orkestra and Deusto Business School Entrepreneuruial Ecosystems Creating Jobs Symposium University of South Australia, Adelaide, 10 July 2018
More informationDigital Masterplanning Steve Turner, Arup
1 1 Digital Masterplanning Steve Turner, Arup Improving productivity and competitiveness. Cities are looking to harness digital technologies because they provide the potential to; deliver better outcomes,
More informationAchievements of FP7 examples that make us proud
Achievements of FP7 examples that make us proud Acknowledgements This booklet is a true, but humble, product of European cooperation, just like the inspiring examples it contains. All of the content was
More information